TMCnet News
INSYS Therapeutics, Inc. to Participate in Oppenheimer Specialty Pharma SummitPHOENIX, Oct. 09, 2017 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the company”) announced today that Saeed Motahari, president and chief executive officer, and Andrew Long, chief financial officer, will participate in the Oppenheimer Specialty Pharma Summit to be held Oct. 11, 2017 at the Sofitel Hotel in New York. Management will provide an overview of the company’s business in one-on-one meetings with investors who are registered to attend the conference. The presentation slides will be available during the conference and can be accessed by visiting the News & Events page of the Investors section of the company’s website at https://www.insysrx.com/. About INSYS SUBSYS® and SYNDROS® are trademarks of INSYS Development Company, Inc., a subsidiary of INSYS Therapeutics, Inc. NOTE: All trademarks and registered trademarks are the property of their respective owners. CONTACT: Media Relations Investor Relations |